Factor Structure of the National Alzheimer's Coordinating Centers Uniform Dataset Neuropsychological Battery An Evaluation of Invariance Between and Within Groups Over Time

Joseph and Kathleen Bryan Alzheimer's Disease Research Center, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27705, USA.
Alzheimer disease and associated disorders (Impact Factor: 2.44). 04/2011; 25(2):128-37. DOI: 10.1097/WAD.0b013e3181ffa76d
Source: PubMed


The neuropsychological battery from the National Alzheimer's Disease Coordinating Center is designed to provide a sensitive assessment of mild cognitive disorders for multicenter investigations. Comprising 8 common neuropsychological tests (12 measures), the battery assesses cognitive domains affected early in the course of Alzheimer disease. We examined the factor structure of the battery across levels of cognition [normal, mild cognitive impairment, dementia] based on Clinical Dementia Rating scores to determine cognitive domains tapped by the battery. Using data pooled from 29 Alzheimer's Disease Centers funded by National Institute on Aging, exploratory factor analysis was used to derive a general model using half of the sample; 4 factors representing memory, attention, executive function, and language were identified. Confirmatory factor analysis was used on the second half of the sample to evaluate invariance between groups and within groups over 1 year. Factorial invariance testing included systematic addition of constraints and comparisons of nested models. The general confirmatory factor analysis model had a good fit. As constraints were added, model fit deteriorated slightly. Comparisons within groups showed stability over 1 year. In a range of cognition from normal to dementia, factor structures and factor loadings will vary little. Further work is needed to determine whether domains become more or less distinct in severely cognitively compromised individuals.

Download full-text


Available from: Jeffrey Browndyke,
  • Source
    • "There is also evidence that the underlying cognitive structure may not be stable during the course of AD (Chapman et al., 2010; Hayden et al., 2011; Johnson, Storandt, Morris, & galvin, 2009; Kanne, Balota, Storandt, McKeel, & Morris, 1998; Siedlecki, Honig, & Stern, 2008). For example , data from one study (Hayden et al., 2011) indicated that across levels of cognition (i.e., normal, mild cognitive impairment [MCi], dementia), the factor structure of cognitive functions varied. Another study (Siedlecki et al., 2008) reporting results from explorative and confirmatory factor analyses suggested that the memory construct represents something different in healthy older adults, questionable dementia, and AD, consistent with the underlying neuropathology . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives. The nature of the association between the cognitive decline and quality of life (QoL) during the course of Alzheimer’s disease (AD) has not been studied in detail. We designed this study to determine if the association between cognitive domains in AD and health-related quality of life (HRQoL) changed more than 18 months. Methods. We recruited 80 community-dwelling older adults with mild to moderate AD and 61 healthy elderly controls as well as their next-of-kin. The primary outcome measure was the QoL-AD. Specific cognitive functions were assessed with a broad range of neuropsychological measures, which were later grouped into cognitive domains following factor analyses at the baseline and 18-month assessments. Other explanatory variables included demographics, psychopathology, burden of care, and use of medication. Results. Self-reported QoL-AD scores were not associated with any of the identified cognitive domains at either assessment. The cognitive domains of people with AD changed between baseline and the 18-month assessment, as did the association of these factors with carer-rated HRQoL. The HRQoL scores assigned by the next-of-kin declined alongside a general measure of cognitive function. Discussion. These results indicate that HRQoL is not consistently associated with specific cognitive domains in AD and that cognitive-enhancing focused therapies may fail to affect the HRQoL of people with AD.
    The Journals of Gerontology Series B Psychological Sciences and Social Sciences 08/2014; DOI:10.1093/geronb/gbu090 · 3.21 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The earliest cognitive deficits observed in amnestic mild cognitive impairment (aMCI) appear to center on memory tasks that require relational memory (RM), the ability to link or integrate unrelated pieces of information. RM impairments in aMCI likely reflect neural changes in the medial temporal lobe (MTL) and posterior parietal cortex (PPC). We tested the hypothesis that individuals with aMCI, as compared to cognitively normal (CN) controls, would recruit neural regions outside of the MTL and PPC to support relational memory. To this end, we directly compared the neural underpinnings of successful relational retrieval in aMCI and CN groups, using event-related functional magnetic resonance imaging (fMRI), holding constant the stimuli and encoding task. The fMRI data showed that the CN, compared to the aMCI, group activated left precuneus, left angular gyrus, right posterior cingulate, and right parahippocampal cortex during relational retrieval, while the aMCI group, relative to the CN group, activated superior temporal gyrus and supramarginal gyrus for this comparison. Such findings indicate an early shift in the functional neural architecture of relational retrieval in aMCI, and may prove useful in future studies aimed at capitalizing on functionally intact neural regions as targets for treatment and slowing of the disease course. (JINS, 2012, 18, 1-12).
    Journal of the International Neuropsychological Society 05/2012; 18(5):886-97. DOI:10.1017/S1355617712000689 · 2.96 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a large multi-center study designed to develop optimized methods for acquiring longitudinal neuroimaging, cognitive, and biomarker measures of AD progression in a large cohort of patients with Alzheimer's disease (AD), patients with Mild Cognitive Impairment, and healthy controls. Detailed neuropsychological testing was conducted on all participants. We examined the factor structure of the ADNI Neuropsychological Battery across older adults with differing levels of clinical AD severity based on the Clinical Dementia Rating Scale (CDR). Confirmatory factor analysis (CFA) of 23 variables from 10 neuropsychological tests resulted in five factors (memory, language, visuospatial functioning, attention, and executive function/processing speed) that were invariant across levels of cognitive impairment. Thus, these five factors can be used as indicators of cognitive function in older adults who are participants in ADNI.
    Brain Imaging and Behavior 07/2012; 6(4). DOI:10.1007/s11682-012-9190-3 · 4.60 Impact Factor
Show more